Dr. Lucci received his medical degree at Texas Tech University School of Medicine, where he was a member of the Alpha Omega Alpha medical honors society. He completed his internship and residency in General Surgery at The Mayo Clinic in Rochester, Minnesota. He then completed a two-year fellowship in Surgical Oncology at The John Wayne Cancer Institute in Santa Monica, California.
Dr. Lucci joined the faculty of Baylor College of Medicine in the Department of Surgery in 1998 as an Assistant Professor, and was promoted to Associate Professor in 2003. During his time at Baylor, Dr. Lucci served as the Associate Director of the General Surgery Residency Program. He was the recipient of a number of honors and awards at Baylor, including the Gene A. Guinn Outstanding Faculty Teaching Award in 1999, the Fulbright & Jaworski L.L.P. Faculty Excellence in Education Award in 2003, and he was named to the Academy of Distinguished Educators in 2003. In December 2003 Dr. Lucci received the Molecular Surgeon Research Achievement Award at Baylor for his work with COX-2 inhibitors and metastasis prevention in breast cancer.
In September of 2004, Dr. Lucci joined the Faculty of The University of Texas MD Anderson Cancer Center as an Associate Professor in The Department of Surgical Oncology. He has served as Principal Investigator for a number of national and international cooperative group clinical trials. He has obtained extramural funding from the NIH and The Department of Defense Breast Cancer Research Program for his work studying mechanisms of breast cancer metastasis. His research program includes translational research on mechanisms of micrometastatic spread of cancer cells to the bone marrow and blood in patients with breast cancer.
Dr. Lucci has published over sixty peer-reviewed scientific papers and book chapters, and is frequently invited to lecture both nationally and internationally. He is a Fellow of the American College of Surgeons, and a member of the Society of Surgical Oncology, The American Society of Clinical Oncology (ASCO), The American Association for Cancer Research (AACR), The Western Surgical Association, The Association for Academic Surgery, The Society of University Surgeons, The Southwestern Surgical Congress, and numerous other medical and scientific societies. He has studied women’s health issues such as factors affecting mastectomy rates, and the use of minimally-invasive biopsy techniques in patients with breast cancer. His primary clinical focus at MD Anderson is in the treatment of patients with breast cancer and melanoma.